Atlas FDA

MagtraceTM and Sentimag(R) Magnetic Locatization System

FDA premarket approval P160053/S005 · decided 2022-09-13

Approval details

PMA number
P160053
Supplement
S005
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
MagtraceTM and Sentimag(R) Magnetic Locatization System
Generic name
Lymph node location system during sentinel biopsy procedure
Applicant
Endomagnetics Ltd.,
Date received
2022-03-24
Decision date
2022-09-13
Days to decision
173 days
Decision code
APPR
Product code
PUV
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Cambridge
Statement
Approved for using new Gen 3 and Gen 3T Sentimag detectors to detect Magtrace, addition of CIDEX OPA as a high level disinfectant for disinfecting Sentimag Gen 3 and Gen 3T detectors, and addition of certain low temperature sterilization systems for certain cycles for sterilization of Sentimag Gen 3 and Gen 3T detectors.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Magseed Pro Magnetic Marker System (K232865)Endomagnetics Ltd.,2024-06-28
Sentimag System (K222832)Endomagnetics Ltd.,2023-01-21
Magseed Magnetic Marker Systtem (K173587)Endomagnetics Ltd.,2018-02-16
Magseed Magnetic Marker System (K163541)Endomagnetics Ltd.,2017-01-13
Sentimag System, Sentimark Magnetic Marker Systerm (K153044)Endomagnetics Ltd.,2016-03-02